BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Skerget M, Skopec B, Zadnik V, Zontar D, Podgornik H, Rebersek K, Furlan T, Cernelc P. CD56 Expression Is an Important Prognostic Factor in Multiple Myeloma Even with Bortezomib Induction. Acta Haematol 2018;139:228-34. [DOI: 10.1159/000489483] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Göçer M, Kurtoğlu E. Is absence of CD56 a predictive factor for peripheral blood stem cell mobilization failure in patients with multiple myeloma? J Clin Apher 2021;36:332-9. [PMID: 33333593 DOI: 10.1002/jca.21864] [Reference Citation Analysis]
2 Inamdar AA, Loo A, Mikhail N, Lee P. Secondary Plasma Cell Leukemia in a Recurrent Multiple Myeloma: Rare Case Scenario. Cureus 2020;12:e8456. [PMID: 32642366 DOI: 10.7759/cureus.8456] [Reference Citation Analysis]
3 Zhang DY, Huang GR, Ku JW, Zhao XK, Song X, Xu RH, Han WL, Zhou FY, Wang R, Wei MX, Wang LD. Development and validation of a prognostic nomogram model for Chinese patients with primary small cell carcinoma of the esophagus. World J Clin Cases 2021; 9(30): 9011-9022 [PMID: 34786384 DOI: 10.12998/wjcc.v9.i30.9011] [Reference Citation Analysis]
4 Ding L, Hu Y, Huang H. Novel progresses of chimeric antigen receptor (CAR) T cell therapy in multiple myeloma. Stem Cell Investig 2021;8:1. [PMID: 33575314 DOI: 10.21037/sci-2020-029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
5 ElMenshawy N, Farag NA, Atia DM, Abousamra N, Shahin D, Fawzi E, Ghazi H, El-Kott AF, Eissa M. Prognostic Relevance of Concordant Expression CD69 and CD56 in Response to Bortezomib Combination Therapy in Multiple Myeloma Patients. Cancer Invest 2021;:1-6. [PMID: 34344244 DOI: 10.1080/07357907.2021.1964521] [Reference Citation Analysis]
6 Okura M, Ida N, Yamauchi T. The clinical significance of CD49e and CD56 for multiple myeloma in the novel agents era. Med Oncol 2020;37:103. [PMID: 33068194 DOI: 10.1007/s12032-020-01423-4] [Reference Citation Analysis]
7 Fliss E, Zaretski A, Cohen Y, Shapira Y, Gur E, Yanko R. Outside the box-Surgery for aggressive plasmacytoma in scar. Clin Case Rep 2021;9:1325-9. [PMID: 33768837 DOI: 10.1002/ccr3.3761] [Reference Citation Analysis]